The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling-Reference-Cited by-同舟云学术

The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling

Published:2008-01-02 Issue:1 Volume:118 Page:64-78
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Brantley-Sieders Dana M.,Zhuang Guanglei,Hicks Donna,Fang Wei Bin,Hwang Yoonha,Cates Justin M.M.,Coffman Karen,Jackson Dowdy,Bruckheimer Elizabeth,Muraoka-Cook Rebecca S.,Chen Jin

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference71 articles.

1. The Hallmarks of Cancer

2. Rules for Making Human Tumor Cells

3. Cancer genes and the pathways they control

4. Oncogenic kinase signalling

5. Eph Receptor Tyrosine Kinases in Angiogenesis: From Development to Disease

Cited by 239 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the EphA2 pathway: could it be the way for bone sarcomas?;Cell Communication and Signaling;2024-09-09

2. Recent advances of the Ephrin and Eph family in cardiovascular development and pathologies;iScience;2024-08

3. hMAGEA2Accelerates the Progression of Prostate Cancerviathe EFNA3–Erk1/2 Signaling Pathway;Anticancer Research;2024-06-26

4. Ephs in cancer progression: complexity and context-dependent nature in signaling, angiogenesis and immunity;Cell Communication and Signaling;2024-05-29

5. Ephrin type-A receptor 2-antisense RNA1/2 promote proliferation and migration of MDA-MB-231 cells through EPHA2-dependent Ras signaling pathway mediated by MAPK8/JNK1, MAPK9/JNK2-NFATC2/NFAT1 and JUND;Frontiers in Molecular Biosciences;2024-05-24